Literature DB >> 1251757

Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine.

P Bech, P B Vendsborg, O J Rafaelsen.   

Abstract

The purpose of this study was to evaluate the desired and undesired effects of relapse-preventive lithium treatment given routinely to manic-melancholic patients who had accepted the necessity of a strict tablet regime. The evaluation was based upon case record data and various rating scales, and 76 patients took part in the investigation. Our results showed that in 24% of the patients treatment was discontinued. This was due to side effects in 16% and to insufficient effect in 8% of the cases. The suicide risk was not eliminated, and 29% of the patients were receiving additional antidepressive or antimanic treatment at the test day. On the other hand, 78% of the patients rated the relapse-preventive lithium effect as moderate to excellent. Indirect evidence was obtained in support of a stabilizing effect of lithium on the emotional control in bipolar patients. The most frequent complaints during lithium treatment were tremor and increased thirst.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1251757     DOI: 10.1111/j.1600-0447.1976.tb00060.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

Review 1.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

2.  Lithium effects on rat brain glucose metabolism in long-term lithium-treated rats studied in vivo.

Authors:  P Plenge
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

3.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

Review 4.  The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure.

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Psychogenic needs in depression.

Authors:  H Perris; E Strandman
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979

6.  Long-term lithium treatment: effect on simulated driving and other psychological tests.

Authors:  P Bech; J Thomsen; O J Rafaelsen
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

7.  Lithium treatment for psychiatric disorders.

Authors:  B M Maletzky; J H Shore
Journal:  West J Med       Date:  1978-06

8.  Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens.

Authors:  M Schou; A Amdisen; K Thomsen; P Vestergaard; O Hetmar; E T Mellerup; P Plenge; O J Rafaelsen
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Treatment-adherence in bipolar disorder: A patient-centred approach.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2016-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.